Antigen presentation by liposomes

Inhibition with antibodies

Peter Walden, Zoltan A. Nagy, Jan Klein

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The involvement of both antigen and class II major histocompatibility complex (MHC) molecules in T cell activation by liposome‐bound antigens was investigated. We used a pigeon cytochrome c (PCC)‐specific Ek‐restricted T cell hybridoma that can be activated to produce interleukin 2 by liposomes carrying either PCC and Ek molecules, or a high concentration of PCC alone. We demonstrated that the MHC‐restricted response of this hybridoma to liposomes is specifically blocked by both anti‐MHC and anti‐PCC monoclonal antibodies, whereas unrestricted activation is only inhibited by PCC‐specific antibody.

Original languageEnglish (US)
Pages (from-to)717-720
Number of pages4
JournalEuropean Journal of Immunology
Volume16
Issue number6
DOIs
StatePublished - Jan 1 1986

Fingerprint

Columbidae
Antigen Presentation
Cytochromes c
Liposomes
Hybridomas
Antibodies
CD27 Antigens
Histocompatibility Antigens Class II
Major Histocompatibility Complex
Interleukin-2
Monoclonal Antibodies
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Walden, Peter ; Nagy, Zoltan A. ; Klein, Jan. / Antigen presentation by liposomes : Inhibition with antibodies. In: European Journal of Immunology. 1986 ; Vol. 16, No. 6. pp. 717-720.
@article{53b4c5c3517b46e2877e969a3898aee6,
title = "Antigen presentation by liposomes: Inhibition with antibodies",
abstract = "The involvement of both antigen and class II major histocompatibility complex (MHC) molecules in T cell activation by liposome‐bound antigens was investigated. We used a pigeon cytochrome c (PCC)‐specific Ek‐restricted T cell hybridoma that can be activated to produce interleukin 2 by liposomes carrying either PCC and Ek molecules, or a high concentration of PCC alone. We demonstrated that the MHC‐restricted response of this hybridoma to liposomes is specifically blocked by both anti‐MHC and anti‐PCC monoclonal antibodies, whereas unrestricted activation is only inhibited by PCC‐specific antibody.",
author = "Peter Walden and Nagy, {Zoltan A.} and Jan Klein",
year = "1986",
month = "1",
day = "1",
doi = "10.1002/eji.1830160622",
language = "English (US)",
volume = "16",
pages = "717--720",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

Antigen presentation by liposomes : Inhibition with antibodies. / Walden, Peter; Nagy, Zoltan A.; Klein, Jan.

In: European Journal of Immunology, Vol. 16, No. 6, 01.01.1986, p. 717-720.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antigen presentation by liposomes

T2 - Inhibition with antibodies

AU - Walden, Peter

AU - Nagy, Zoltan A.

AU - Klein, Jan

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The involvement of both antigen and class II major histocompatibility complex (MHC) molecules in T cell activation by liposome‐bound antigens was investigated. We used a pigeon cytochrome c (PCC)‐specific Ek‐restricted T cell hybridoma that can be activated to produce interleukin 2 by liposomes carrying either PCC and Ek molecules, or a high concentration of PCC alone. We demonstrated that the MHC‐restricted response of this hybridoma to liposomes is specifically blocked by both anti‐MHC and anti‐PCC monoclonal antibodies, whereas unrestricted activation is only inhibited by PCC‐specific antibody.

AB - The involvement of both antigen and class II major histocompatibility complex (MHC) molecules in T cell activation by liposome‐bound antigens was investigated. We used a pigeon cytochrome c (PCC)‐specific Ek‐restricted T cell hybridoma that can be activated to produce interleukin 2 by liposomes carrying either PCC and Ek molecules, or a high concentration of PCC alone. We demonstrated that the MHC‐restricted response of this hybridoma to liposomes is specifically blocked by both anti‐MHC and anti‐PCC monoclonal antibodies, whereas unrestricted activation is only inhibited by PCC‐specific antibody.

UR - http://www.scopus.com/inward/record.url?scp=0022521874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022521874&partnerID=8YFLogxK

U2 - 10.1002/eji.1830160622

DO - 10.1002/eji.1830160622

M3 - Article

VL - 16

SP - 717

EP - 720

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -